EC Pilot to Test Benefits of Early Talks Between Drugmakers, HTAs

International Pharmaceutical Regulatory Monitor
A A
The European Commission is looking for drugmakers to participate in pilots on early dialogue with health technology assessors, with the aim of better aligning new product development and HTA requirements.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00